Ketoconazole/MetyraponeHepatotoxicity and off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2032卷 / 1期

关键词：

D O I：

10.1007/s40278-024-69889-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：228 / 228

相关论文

共 50 条

[41] NifedipineLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1918 (1) : 386 - 386
[42] DaratumumabHypogammaglobulinemia following off-label use: case report
Reactions Weekly, 2020, 1802 (1) : 114 - 114
[43] DexamethasoneInsulin resistance and off-label use: case report
Reactions Weekly, 2022, 1911 (1) : 173 - 173
[44] DapsoneMethaemoglobinaemia following off-label use: case report
Reactions Weekly, 2021, 1843 (1) : 130 - 130
[45] NalbuphineBradycardia following an off-label use: case report
Reactions Weekly, 2019, 1753 (1) : 255 - 255
[46] OsimertinibPneumonitis secondary to off-label use: case report
Reactions Weekly, 2020, 1814 (1) : 283 - 283
[47] TocilizumabLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1954 (1) : 409 - 409
[48] DimeticoneGranuloma following off-label use: case report
Reactions Weekly, 2023, 1980 (1) : 150 - 150
[49] CyproteroneMeningiomas following off-label use: case report
Reactions Weekly, 2021, 1849 (1) : 152 - 152
[50] Atropine/clozapineSialorrhoea and off-label use: case report
Reactions Weekly, 2024, 2028 (1) : 78 - 78

← 1 2 3 4 5 →